Zenas BioPharma (ZBIO) Earnings Analysis
Zenas BioPharma (ZBIO) next reports earnings on 2026-08-11, consensus EPS -0.89 USD. Last quarter (2026-03-16) it missed with EPS -1.1 USD vs -1.00141 USD est (-9.8%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -3.46.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ZBIO next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -0.89 USD |
| Revenue estimate | 0.01B |
ZBIO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-16 | -1.1 USD | -1.00141 USD | -9.8% | Miss |
| 2025-05-15 | -0.8 USD | -1.11 USD | +27.9% | Beat |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
ZBIO valuation and analyst view
| Trailing P/E | -3.46 |
|---|---|
| Trailing EPS | -7.64321 USD |
| Price / book | 5.22 |
| Dividend yield | 0.00% |
| Market cap | 1.42B |
| Analyst consensus | Buy (4 buy / 1 hold / 0 sell) |
| Avg price target | 22 USD |
Related research pages
Frequently asked questions
When is Zenas BioPharma (ZBIO)'s next earnings date?
Zenas BioPharma is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.89 USD and revenue estimate of 0.01B.
Did ZBIO beat earnings last quarter?
In its 2026-03-16 report, ZBIO posted EPS of -1.1 USD versus a -1.00141 USD estimate — a miss of 9.8%.
What is ZBIO's earnings track record?
Over the last 2 reported quarters with consensus data, ZBIO beat estimates 1 times (50%).
What is ZBIO's current P/E ratio and EPS?
ZBIO trades at a trailing P/E of -3.46 on trailing EPS of -7.643214747797608 USD.
What do analysts rate ZBIO?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 22 USD.